THALOMID

Swiss trademark · 474846 · Word mark · In force

Register entry

Registration number
474846
Application number
02175/2000
Status
In force
Type
Word mark
Filed
Feb 25, 2000
Registered
Aug 3, 2000
Published
Aug 29, 2000
Protected until
Feb 25, 2030
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Erzeugnisse, insbesondere Zytokin-hemmende Medikamente.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 22, 2021

    Agent removed

    Representative
    Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex (removed)

    Published in Swissreg on 22.06.2021

  2. Jun 22, 2021

    Agent entered

    Representative
    Troller Hitz Troller, Rechtsanwälte, Schweizerhofquai 2, Postfach, 6002 Luzern

    Published in Swissreg on 22.06.2021

  3. Jan 16, 2020

    Renewed

    Published in Swissreg on 16.01.2020

  4. Nov 10, 2009

    Agent entered

    Representative
    Hepp, Wenger & Ryffel AG, Friedtalweg 5, 9500 Wil SG → Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex

    Published in Swissreg on 10.11.2009

  5. Nov 10, 2009

    Renewed

    Published in Swissreg on 10.11.2009

  6. Feb 24, 2009

    Holder’s address changed

    Owner
    Celgene Corporation, 7 Powder Horn Drive, Warren (NJ), USA → Celgene Corporation, 86 Morris Avenue, Summit (NJ 07901), USA

    Published in Swissreg on 24.02.2009

  7. Aug 29, 2000

    Registered

    Published in the SOGC no. 167 of 29.08.2000

Parties

Holder

Celgene Corporation

86 Morris Avenue, Summit (NJ 07901), US

Agent

Troller Hitz Troller, Rechtsanwälte

Schweizerhofquai 2 Postfach, 6002 Luzern

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.